Search results
Website. www .bms .com. Juno Therapeutics Inc was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.
- 2013
- Biotechnology
Feb 8, 2022 · Juno’s success reverberated throughout biotech in Seattle and beyond, fueling interest in cell and gene therapy and providing a blueprint for the next generation of startups founded in its wake.
Jan 22, 2018 · Celgene has agreed to buy CAR-T specialist Juno Therapeutics for around $9 billion in a deal that instantly makes it a big cheese in this emerging therapeutic category. The definitive terms...
People also ask
Who is Juno Therapeutics?
Who bought Juno Therapeutics?
Does Celgene own Juno Therapeutics?
How much money did Juno Therapeutics raise?
Juno Therapeutics, Inc. | LinkedIn. Biotechnology Research. Seattle, WA 27,598 followers. View all 136 employees. About us. We have merged with Bristol Myers Squibb creating a leading biopharma...
Jan 22, 2018 · Juno is a pioneer in the development of CAR (chimeric antigen receptor) T and TCR (T cell receptor) therapeutics with a broad, novel portfolio evaluating multiple targets and cancer indications.
Sep 12, 2016 · Bhavneesh Sharma. Investing Group Leader. Follow. Summary. Shares of Juno Therapeutics have seen a pull-back after the news of two patient deaths in its pivotal ROCKET trial testing its CAR...
Nov 1, 2017 · David Crow. November 1 2017. Unlock the Editor’s Digest for free. Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Shares in Juno Therapeutics jumped by...
